Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for RCAR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
September 30, 2022 -0.1482M
June 30, 2022 -1.626M
March 31, 2022 -1.779M
December 31, 2021 -0.5726M
September 30, 2021 -0.9212M
June 30, 2021 -1.265M
March 31, 2021 -1.805M
December 31, 2020 -1.258M
September 30, 2020 -1.546M
June 30, 2020 -1.124M
March 31, 2020 -0.7952M
December 31, 2019 -1.189M
September 30, 2019 -0.8982M
June 30, 2019 -0.671M
March 31, 2019 -0.454M
December 31, 2018 -0.6619M
September 30, 2018 -0.3016M
June 30, 2018 -0.4314M
March 31, 2018 -0.6314M
December 31, 2017 -0.5184M
September 30, 2017 -0.3909M
June 30, 2017 -0.4298M
March 31, 2017 -0.3349M
December 31, 2016 -0.3788M
September 30, 2016 -0.2884M
Date Value
June 30, 2016 -0.5618M
March 31, 2016 -0.5597M
December 31, 2015 -0.5083M
September 30, 2015 -0.2567M
June 30, 2015 -0.2181M
March 31, 2015 -0.3125M
December 31, 2014 -0.2067M
September 30, 2014 -0.2783M
June 30, 2014 -0.1812M
March 31, 2014 -0.1596M
December 31, 2013 -0.1753M
September 30, 2013 -0.0502M
June 30, 2013 -0.0979M
March 31, 2013 -0.0265M
December 31, 2012 -0.0612M
September 30, 2012 -0.0246M
June 30, 2012 -0.0558M
March 31, 2012 -0.1257M
December 31, 2011 -0.1763M
September 30, 2011 -0.1752M
June 30, 2011 -0.2663M
March 31, 2011 -0.1297M
December 31, 2010 -0.1276M
September 30, 2010 -0.0872M
June 30, 2010 -0.0556M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
Marizyme, Inc. --
Mera Pharmaceuticals, Inc. --
Nanologix, Inc. --
PhaseRx, Inc. --